Read on Wikipedia

Image: Vaccinationist · CC BY-SA 4.0

Orforglipron

Orforglipron

Anti-obesity medication.

Super rare
278 views/day0 owners

No account needed. By playing, you confirm you're 13 or older and agree to the Terms of use.

No owners yet

Super rareTop 12%

Category: Empty

0 owners
0 copies
0 pulls
Wishlisted
0
In 0 albums
On 0 showcases
Market listings
0
Wikipedia views per dayLast 30 days 7,533

Not sold on the market yet.

Readers' pathsAug 2026 – Oct 2026

Readers go next to

Share of the 3,461 clicks on its links

  1. Chugai

    Japanese pharmaceutical company.

    25%

  2. Retatrutide

    Chemical compound.

    8.3%

  3. Dulaglutide

    Diabetes medication.

    7.9%

  4. Tirzepatide

    Anti-diabetic and anti-obesity medication.

    7.7%

  5. Eli Lilly and Company

    American pharmaceutical company.

    6%

  6. Glucagon-like peptide-1

    Gastrointestinal peptide hormone involved in glucose homeostasis.

    5.4%

  7. Cyclic adenosine monophosphate

    Cellular second messenger.

    3.2%

  8. Semaglutide

    Anti-diabetic and anti-obesity medication.

    2%

  9. Skeletal formula

    Representation method in chemistry.

    0.29%

Readers come from

Share of the 825 readers arriving from another article

  1. Retatrutide

    Chemical compound.

    35%

  2. Danuglipron

    Chemical compound.

    9.1%

  3. Glucagon-like peptide-1 receptor

    Receptor activated by peptide hormone GLP-1.

    5.2%

  4. Lotiglipron

    Chemical compound.

    5.1%

  5. Tirzepatide

    Anti-diabetic and anti-obesity medication.

    4.5%

  6. Semaglutide

    Anti-diabetic and anti-obesity medication.

    1.2%